Related Articles
Hormone receptor measurements and survival in 1335 consecutive patients with primary invasive breast carcinoma.
13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group
Transcriptomic signature predicts the distant relapse in patients with ER+ breast cancer treated with tamoxifen for five years
PATHOBIOLOGICAL CHARACTERISTICS OF THE 1ST PRIMARY AND RISK OF METACHRONOUS CONTRALATERAL INVASIVE BREAST-CARCINOMA - CLINICAL IMPLICATIONS
Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine‑dependent breast cancer: A report of two cases